0.00
—
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Biolife Sciences
Its shares trade under the ticker BLFE. It has been listed since 25 April 2005. In the fiscal year to 30 November 2020, it reported revenue of $411,695 and a net loss of $1.3m. At that date it held total assets of $72,718 and shareholders' equity of −$689,583.
Bio Life Sciences, Inc. engages in the development of mobile applications and Voice over Internet Protocol (VoIP) services. The company is headquartered in New York City, New York. The company went IPO on 2005-04-25. The Company’s core business develops, licenses and distributes antimicrobial products, non-contract human temperature screening technology and touchless vending products. Its technology solutions include BioLife Eco-Safe Surface Sanitizer, which is a botanically-derived disinfectant that kills bacteria, fungi and viruses; Antimicrobial Copper Air Filters cleans the air and releases copper ions to protect against bacteria and germs found circulating in enclosed rooms and buildings and BioLife Intelligent Touchless Vending and Marketplaces that provides digital advertising and digital vending machines serving a wide range of personal protective equipment and antimicrobial products. Its non-contract human temperature screening technology solutions detects subjects’ body temperature.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 25 Apr 2005
- Employees
- 565
Leadership
Pay as last reported
- Mr. Justin De FourChairman of the Board, Chief Executive Officer, since 2020
- John RudyChief Financial Officer, Vice President$37,602
- Lloyd GlickChief Operating Officer
- Mr. Arthur ViolaSecretary, Director, since 2002$162,500
- Dr. Nataliya HearnDirector
- Mr. Brian MoralesDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Biolife Sciences Inc has a strong research and development team that constantly innovates new products and technologies.
- The company has a wide range of patents and intellectual property rights, providing a competitive advantage in the market.
- Biolife Sciences Inc has established a solid reputation for producing high-quality and reliable products, gaining trust from customers.
Weaknesses
- The company heavily relies on a small number of key suppliers, which exposes it to supply chain disruptions and price fluctuations.
- Biolife Sciences Inc has limited market presence in certain geographical regions, missing out on potential opportunities for growth.
- The organization faces challenges in managing rapid growth, which may lead to issues in maintaining operational efficiency.
Opportunities
- The increasing global demand for bio-based products presents an opportunity for Biolife Sciences Inc to expand its market share.
- Strategic partnerships with large pharmaceutical companies can open doors for Biolife Sciences Inc to enter new markets and leverage their distribution networks.
- Technological advancements in the industry offer possibilities for Biolife Sciences Inc to develop innovative and cutting-edge solutions.
Threats
- Intense competition from both established players and emerging startups poses a threat to Biolife Sciences Inc's market position.
- Regulatory changes and compliance requirements in the industry can impact the company's operations and increase costs.
- Global economic fluctuations and trade policies may affect Biolife Sciences Inc's export opportunities and revenue growth.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.